Advertisement
Screener

Ghost Tree Capital, LLC Historic Quarter Change: Foreign ADRs, Reduced

Ghost Tree Capital, LLC historic quarter change: Foreign ADRs, Reduced

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 14 quarters from 2013-12-31 to 2024-09-30, Ghost Tree Capital, LLC opened 14 positions, added to 6, reduced 8 and sold out of 13.

  • Q3 2024: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 86,721.
  • Q1 2016: Stock DBV TECHNOLOGIES S A; Country of operation —; Class SPONSORED ADR; Shares before 80,000.
  • Q1 2016: Stock AKARI THERAPEUTICS PLC; Country of operation —; Class SPONSORED ADR; Shares before 47,116.
  • Q3 2015: Stock FLAMEL TECHNOLOGIES SA; Country of operation —; Class SPONSORED ADR; Shares before 575,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1595851), 14 quarters: Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-17); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-09-09); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2013-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2024ASCENDIS PHARMA A/S
CUSIP 04351P101
SPONSORED ADR86,72152,500-34,221$11,827,010$7,838,775-$3,988,2352024-11-14
Q1 2016DBV TECHNOLOGIES S A
CUSIP 23306J101
SPONSORED ADR80,00045,000-35,000$5,314,000$2,583,000-$2,731,0002016-05-16
Q1 2016AKARI THERAPEUTICS PLC
CUSIP 00972G108
SPONSORED ADR47,11646,622-494$683,000$653,000-$30,0002016-05-16
Q3 2015FLAMEL TECHNOLOGIES SA
CUSIP 338488109
SPONSORED ADR575,000350,000-225,000$12,184,000$5,709,000-$6,475,0002015-11-16
Q3 2015GW PHARMACEUTICALS PLC
CUSIP 36197T103
ADS75,00030,000-45,000$9,213,000$2,741,000-$6,472,0002015-11-16
Q1 2015FLAMEL TECHNOLOGIES SA
CUSIP 338488109
SPONSORED ADR325,000200,000-125,000$5,567,000$3,596,000-$1,971,0002015-05-15
Q2 2014FLAMEL TECHNOLOGIES SA
CUSIP 338488109
SPONSORED ADR300,00075,000-225,000$4,020,000$1,125,000-$2,895,0002014-08-14
Q2 2014GW PHARMACEUTICALS PLC
CUSIP 36197T103
ADS25,00020,000-5,000$1,484,000$2,146,000+$662,0002014-08-14

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet